Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina

Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia–reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 2004-07, Vol.1015 (1), p.154-160
Hauptverfasser: Sakamoto, Kenji, Yonoki, Yuzuru, Kuwagata, Mayumi, Saito, Maki, Nakahara, Tsutomu, Ishii, Kunio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 160
container_issue 1
container_start_page 154
container_title Brain research
container_volume 1015
creator Sakamoto, Kenji
Yonoki, Yuzuru
Kuwagata, Mayumi
Saito, Maki
Nakahara, Tsutomu
Ishii, Kunio
description Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia–reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histological examination. Male Sprague–Dawley rats were subjected to 60 min of retinal ischemia by raising intraocular pressure to 130 mm Hg. Ischemic preconditioning was achieved by applying 5 min of ischemia 5–60 min before 60 min of ischemia. Additional groups of rats received 10 mg/kg 8-phenyltheophiline and 4.5 mg/kg 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), adenosine A 1 receptor antagonists, 5 mg/kg 5-hydroxydecanoate and 1 mg/kg glibenclamide, ATP-sensitive K + channel blockers, or 2.5 mg/kg chelerythrine and 0.1 mg/kg bisindolylmaleimide I, protein kinase C inhibitors, 15 or 30 min before preconditioning. In the non-preconditioned group, cell loss in the ganglion cell layer and thinning of the inner plexiform and inner nuclear layer were observed 7 days after 60 min of ischemia. Five minutes of preconditioning ischemia 20–40 min before 60 min of sustained ischemia completely prevented the retinal tissue damage induced by the sustained ischemia. Treatment with 8-phenyltheophylline, DPCPX, 5-hydroxydecanoate, glibenclamide, chelerythrine and bisindolylmaleimide I almost completely reduced the protective effect of early ischemic preconditioning. The results in the present study indicated that early ischemic preconditioning was demonstrated in the rat retina. Stimulation of adenosine receptors, opening of ATP-sensitive K + channels and activation of protein kinase C might be involved in the underlying protective mechanisms.
doi_str_mv 10.1016/j.brainres.2004.04.074
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66660631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899304007206</els_id><sourcerecordid>17851796</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-ffc0560278445310e82fbe63525545c1926f10cabd107c341460c9a54639e72a3</originalsourceid><addsrcrecordid>eNqFkc9u1DAQxq0KRJfCK1S5wC3L-E_s-AaqKEWqxAXOluNMtl4lzmI7SHvjHXhDnqSOdiu41RrJsuY3n2fmI-SawpYClR_22y5aHyKmLQMQ2zWUuCAb2ipWSybgBdkAgKxbrfkleZ3Svjw51_CKXNKGMc6V3pDpzqc8j_POOztWhzhndNnPobK7Ip9y5ZN7wMnbv7__RDxgHJa0pn3YL_FYdccKbRyPT5grEujm0PtVxIddAatocxUx-2DfkJeDHRO-Pd9X5Mft5-83d_X9ty9fbz7d105omuthcNBIYKoVouEUsGVDh5I3rGlE46hmcqDgbNdTUI4LKiQ4bRshuUbFLL8i70-6ZaCfC6ZsptIgjqMNOC_JyHJAcvosSFXbUKVlAeUJdHFOKeJgDtFPNh4NBbM6YvbmyRGzOmLWUKIUXp9_WLoJ-39lZwsK8O4M2FQ8GKINzqf_OM21AFa4jycOy-J-eYwmOY_BYe_LyrPpZ_9cL4--_a9_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17851796</pqid></control><display><type>article</type><title>Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sakamoto, Kenji ; Yonoki, Yuzuru ; Kuwagata, Mayumi ; Saito, Maki ; Nakahara, Tsutomu ; Ishii, Kunio</creator><creatorcontrib>Sakamoto, Kenji ; Yonoki, Yuzuru ; Kuwagata, Mayumi ; Saito, Maki ; Nakahara, Tsutomu ; Ishii, Kunio</creatorcontrib><description>Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia–reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histological examination. Male Sprague–Dawley rats were subjected to 60 min of retinal ischemia by raising intraocular pressure to 130 mm Hg. Ischemic preconditioning was achieved by applying 5 min of ischemia 5–60 min before 60 min of ischemia. Additional groups of rats received 10 mg/kg 8-phenyltheophiline and 4.5 mg/kg 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), adenosine A 1 receptor antagonists, 5 mg/kg 5-hydroxydecanoate and 1 mg/kg glibenclamide, ATP-sensitive K + channel blockers, or 2.5 mg/kg chelerythrine and 0.1 mg/kg bisindolylmaleimide I, protein kinase C inhibitors, 15 or 30 min before preconditioning. In the non-preconditioned group, cell loss in the ganglion cell layer and thinning of the inner plexiform and inner nuclear layer were observed 7 days after 60 min of ischemia. Five minutes of preconditioning ischemia 20–40 min before 60 min of sustained ischemia completely prevented the retinal tissue damage induced by the sustained ischemia. Treatment with 8-phenyltheophylline, DPCPX, 5-hydroxydecanoate, glibenclamide, chelerythrine and bisindolylmaleimide I almost completely reduced the protective effect of early ischemic preconditioning. The results in the present study indicated that early ischemic preconditioning was demonstrated in the rat retina. Stimulation of adenosine receptors, opening of ATP-sensitive K + channels and activation of protein kinase C might be involved in the underlying protective mechanisms.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/j.brainres.2004.04.074</identifier><identifier>PMID: 15223379</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Adenosine receptor ; Adrenergic alpha-Antagonists - pharmacology ; Animals ; Biological and medical sciences ; Enzyme Inhibitors - pharmacology ; Intraocular Pressure - physiology ; Ischemia - pathology ; Ischemic Preconditioning ; K + channel ; Male ; Medical sciences ; Ophthalmology ; Potassium Channel Blockers - pharmacology ; Protein kinase C ; Purinergic P1 Receptor Antagonists ; Rats ; Rats, Sprague-Dawley ; Reperfusion ; Reperfusion Injury - pathology ; Reperfusion Injury - prevention &amp; control ; Retina - drug effects ; Retina - pathology ; Retinal ischemia ; Retinal Vessels ; Retinopathies ; Theophylline - analogs &amp; derivatives ; Theophylline - pharmacology ; Time Factors ; Xanthines - pharmacology</subject><ispartof>Brain research, 2004-07, Vol.1015 (1), p.154-160</ispartof><rights>2004 Elsevier B.V.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-ffc0560278445310e82fbe63525545c1926f10cabd107c341460c9a54639e72a3</citedby><cites>FETCH-LOGICAL-c491t-ffc0560278445310e82fbe63525545c1926f10cabd107c341460c9a54639e72a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.brainres.2004.04.074$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15939402$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15223379$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakamoto, Kenji</creatorcontrib><creatorcontrib>Yonoki, Yuzuru</creatorcontrib><creatorcontrib>Kuwagata, Mayumi</creatorcontrib><creatorcontrib>Saito, Maki</creatorcontrib><creatorcontrib>Nakahara, Tsutomu</creatorcontrib><creatorcontrib>Ishii, Kunio</creatorcontrib><title>Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia–reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histological examination. Male Sprague–Dawley rats were subjected to 60 min of retinal ischemia by raising intraocular pressure to 130 mm Hg. Ischemic preconditioning was achieved by applying 5 min of ischemia 5–60 min before 60 min of ischemia. Additional groups of rats received 10 mg/kg 8-phenyltheophiline and 4.5 mg/kg 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), adenosine A 1 receptor antagonists, 5 mg/kg 5-hydroxydecanoate and 1 mg/kg glibenclamide, ATP-sensitive K + channel blockers, or 2.5 mg/kg chelerythrine and 0.1 mg/kg bisindolylmaleimide I, protein kinase C inhibitors, 15 or 30 min before preconditioning. In the non-preconditioned group, cell loss in the ganglion cell layer and thinning of the inner plexiform and inner nuclear layer were observed 7 days after 60 min of ischemia. Five minutes of preconditioning ischemia 20–40 min before 60 min of sustained ischemia completely prevented the retinal tissue damage induced by the sustained ischemia. Treatment with 8-phenyltheophylline, DPCPX, 5-hydroxydecanoate, glibenclamide, chelerythrine and bisindolylmaleimide I almost completely reduced the protective effect of early ischemic preconditioning. The results in the present study indicated that early ischemic preconditioning was demonstrated in the rat retina. Stimulation of adenosine receptors, opening of ATP-sensitive K + channels and activation of protein kinase C might be involved in the underlying protective mechanisms.</description><subject>Adenosine receptor</subject><subject>Adrenergic alpha-Antagonists - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Intraocular Pressure - physiology</subject><subject>Ischemia - pathology</subject><subject>Ischemic Preconditioning</subject><subject>K + channel</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Ophthalmology</subject><subject>Potassium Channel Blockers - pharmacology</subject><subject>Protein kinase C</subject><subject>Purinergic P1 Receptor Antagonists</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reperfusion</subject><subject>Reperfusion Injury - pathology</subject><subject>Reperfusion Injury - prevention &amp; control</subject><subject>Retina - drug effects</subject><subject>Retina - pathology</subject><subject>Retinal ischemia</subject><subject>Retinal Vessels</subject><subject>Retinopathies</subject><subject>Theophylline - analogs &amp; derivatives</subject><subject>Theophylline - pharmacology</subject><subject>Time Factors</subject><subject>Xanthines - pharmacology</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9u1DAQxq0KRJfCK1S5wC3L-E_s-AaqKEWqxAXOluNMtl4lzmI7SHvjHXhDnqSOdiu41RrJsuY3n2fmI-SawpYClR_22y5aHyKmLQMQ2zWUuCAb2ipWSybgBdkAgKxbrfkleZ3Svjw51_CKXNKGMc6V3pDpzqc8j_POOztWhzhndNnPobK7Ip9y5ZN7wMnbv7__RDxgHJa0pn3YL_FYdccKbRyPT5grEujm0PtVxIddAatocxUx-2DfkJeDHRO-Pd9X5Mft5-83d_X9ty9fbz7d105omuthcNBIYKoVouEUsGVDh5I3rGlE46hmcqDgbNdTUI4LKiQ4bRshuUbFLL8i70-6ZaCfC6ZsptIgjqMNOC_JyHJAcvosSFXbUKVlAeUJdHFOKeJgDtFPNh4NBbM6YvbmyRGzOmLWUKIUXp9_WLoJ-39lZwsK8O4M2FQ8GKINzqf_OM21AFa4jycOy-J-eYwmOY_BYe_LyrPpZ_9cL4--_a9_</recordid><startdate>20040723</startdate><enddate>20040723</enddate><creator>Sakamoto, Kenji</creator><creator>Yonoki, Yuzuru</creator><creator>Kuwagata, Mayumi</creator><creator>Saito, Maki</creator><creator>Nakahara, Tsutomu</creator><creator>Ishii, Kunio</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20040723</creationdate><title>Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina</title><author>Sakamoto, Kenji ; Yonoki, Yuzuru ; Kuwagata, Mayumi ; Saito, Maki ; Nakahara, Tsutomu ; Ishii, Kunio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-ffc0560278445310e82fbe63525545c1926f10cabd107c341460c9a54639e72a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenosine receptor</topic><topic>Adrenergic alpha-Antagonists - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Intraocular Pressure - physiology</topic><topic>Ischemia - pathology</topic><topic>Ischemic Preconditioning</topic><topic>K + channel</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Ophthalmology</topic><topic>Potassium Channel Blockers - pharmacology</topic><topic>Protein kinase C</topic><topic>Purinergic P1 Receptor Antagonists</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reperfusion</topic><topic>Reperfusion Injury - pathology</topic><topic>Reperfusion Injury - prevention &amp; control</topic><topic>Retina - drug effects</topic><topic>Retina - pathology</topic><topic>Retinal ischemia</topic><topic>Retinal Vessels</topic><topic>Retinopathies</topic><topic>Theophylline - analogs &amp; derivatives</topic><topic>Theophylline - pharmacology</topic><topic>Time Factors</topic><topic>Xanthines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakamoto, Kenji</creatorcontrib><creatorcontrib>Yonoki, Yuzuru</creatorcontrib><creatorcontrib>Kuwagata, Mayumi</creatorcontrib><creatorcontrib>Saito, Maki</creatorcontrib><creatorcontrib>Nakahara, Tsutomu</creatorcontrib><creatorcontrib>Ishii, Kunio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakamoto, Kenji</au><au>Yonoki, Yuzuru</au><au>Kuwagata, Mayumi</au><au>Saito, Maki</au><au>Nakahara, Tsutomu</au><au>Ishii, Kunio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>2004-07-23</date><risdate>2004</risdate><volume>1015</volume><issue>1</issue><spage>154</spage><epage>160</epage><pages>154-160</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia–reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histological examination. Male Sprague–Dawley rats were subjected to 60 min of retinal ischemia by raising intraocular pressure to 130 mm Hg. Ischemic preconditioning was achieved by applying 5 min of ischemia 5–60 min before 60 min of ischemia. Additional groups of rats received 10 mg/kg 8-phenyltheophiline and 4.5 mg/kg 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), adenosine A 1 receptor antagonists, 5 mg/kg 5-hydroxydecanoate and 1 mg/kg glibenclamide, ATP-sensitive K + channel blockers, or 2.5 mg/kg chelerythrine and 0.1 mg/kg bisindolylmaleimide I, protein kinase C inhibitors, 15 or 30 min before preconditioning. In the non-preconditioned group, cell loss in the ganglion cell layer and thinning of the inner plexiform and inner nuclear layer were observed 7 days after 60 min of ischemia. Five minutes of preconditioning ischemia 20–40 min before 60 min of sustained ischemia completely prevented the retinal tissue damage induced by the sustained ischemia. Treatment with 8-phenyltheophylline, DPCPX, 5-hydroxydecanoate, glibenclamide, chelerythrine and bisindolylmaleimide I almost completely reduced the protective effect of early ischemic preconditioning. The results in the present study indicated that early ischemic preconditioning was demonstrated in the rat retina. Stimulation of adenosine receptors, opening of ATP-sensitive K + channels and activation of protein kinase C might be involved in the underlying protective mechanisms.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>15223379</pmid><doi>10.1016/j.brainres.2004.04.074</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 2004-07, Vol.1015 (1), p.154-160
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_66660631
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adenosine receptor
Adrenergic alpha-Antagonists - pharmacology
Animals
Biological and medical sciences
Enzyme Inhibitors - pharmacology
Intraocular Pressure - physiology
Ischemia - pathology
Ischemic Preconditioning
K + channel
Male
Medical sciences
Ophthalmology
Potassium Channel Blockers - pharmacology
Protein kinase C
Purinergic P1 Receptor Antagonists
Rats
Rats, Sprague-Dawley
Reperfusion
Reperfusion Injury - pathology
Reperfusion Injury - prevention & control
Retina - drug effects
Retina - pathology
Retinal ischemia
Retinal Vessels
Retinopathies
Theophylline - analogs & derivatives
Theophylline - pharmacology
Time Factors
Xanthines - pharmacology
title Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T11%3A54%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Histological%20protection%20against%20ischemia%E2%80%93reperfusion%20injury%20by%20early%20ischemic%20preconditioning%20in%20rat%20retina&rft.jtitle=Brain%20research&rft.au=Sakamoto,%20Kenji&rft.date=2004-07-23&rft.volume=1015&rft.issue=1&rft.spage=154&rft.epage=160&rft.pages=154-160&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/j.brainres.2004.04.074&rft_dat=%3Cproquest_cross%3E17851796%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17851796&rft_id=info:pmid/15223379&rft_els_id=S0006899304007206&rfr_iscdi=true